![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RBM4B |
Gene summary for RBM4B |
![]() |
Gene information | Species | Human | Gene symbol | RBM4B | Gene ID | 83759 |
Gene name | RNA binding motif protein 4B | |
Gene Alias | RBM30 | |
Cytomap | 11q13.2 | |
Gene Type | protein-coding | GO ID | GO:0000375 | UniProtAcc | E9PLB0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
83759 | RBM4B | LZE2T | Human | Esophagus | ESCC | 2.16e-04 | 3.90e-01 | 0.082 |
83759 | RBM4B | LZE4T | Human | Esophagus | ESCC | 1.34e-07 | 2.17e-01 | 0.0811 |
83759 | RBM4B | LZE7T | Human | Esophagus | ESCC | 2.70e-05 | 3.26e-01 | 0.0667 |
83759 | RBM4B | LZE8T | Human | Esophagus | ESCC | 1.84e-03 | 1.65e-01 | 0.067 |
83759 | RBM4B | LZE20T | Human | Esophagus | ESCC | 1.37e-07 | 3.27e-01 | 0.0662 |
83759 | RBM4B | LZE22T | Human | Esophagus | ESCC | 6.43e-04 | 2.83e-01 | 0.068 |
83759 | RBM4B | LZE24T | Human | Esophagus | ESCC | 1.00e-15 | 4.31e-01 | 0.0596 |
83759 | RBM4B | LZE6T | Human | Esophagus | ESCC | 4.58e-04 | 1.95e-01 | 0.0845 |
83759 | RBM4B | P1T-E | Human | Esophagus | ESCC | 1.18e-05 | 3.06e-01 | 0.0875 |
83759 | RBM4B | P2T-E | Human | Esophagus | ESCC | 1.16e-24 | 3.53e-01 | 0.1177 |
83759 | RBM4B | P4T-E | Human | Esophagus | ESCC | 1.51e-32 | 7.52e-01 | 0.1323 |
83759 | RBM4B | P5T-E | Human | Esophagus | ESCC | 1.34e-15 | 3.51e-01 | 0.1327 |
83759 | RBM4B | P8T-E | Human | Esophagus | ESCC | 1.08e-26 | 4.97e-01 | 0.0889 |
83759 | RBM4B | P9T-E | Human | Esophagus | ESCC | 2.74e-16 | 3.19e-01 | 0.1131 |
83759 | RBM4B | P10T-E | Human | Esophagus | ESCC | 3.18e-24 | 3.63e-01 | 0.116 |
83759 | RBM4B | P11T-E | Human | Esophagus | ESCC | 9.86e-19 | 6.60e-01 | 0.1426 |
83759 | RBM4B | P12T-E | Human | Esophagus | ESCC | 1.95e-26 | 4.95e-01 | 0.1122 |
83759 | RBM4B | P15T-E | Human | Esophagus | ESCC | 8.83e-13 | 3.41e-01 | 0.1149 |
83759 | RBM4B | P16T-E | Human | Esophagus | ESCC | 6.81e-23 | 4.35e-01 | 0.1153 |
83759 | RBM4B | P17T-E | Human | Esophagus | ESCC | 3.85e-05 | 2.13e-01 | 0.1278 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0008380111 | Esophagus | ESCC | RNA splicing | 336/8552 | 434/18723 | 1.74e-42 | 3.67e-39 | 336 |
GO:0000375111 | Esophagus | ESCC | RNA splicing, via transesterification reactions | 248/8552 | 324/18723 | 3.05e-30 | 1.49e-27 | 248 |
GO:0000377111 | Esophagus | ESCC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 244/8552 | 320/18723 | 2.52e-29 | 1.07e-26 | 244 |
GO:0000398111 | Esophagus | ESCC | mRNA splicing, via spliceosome | 244/8552 | 320/18723 | 2.52e-29 | 1.07e-26 | 244 |
GO:0006417111 | Esophagus | ESCC | regulation of translation | 304/8552 | 468/18723 | 1.53e-17 | 1.33e-15 | 304 |
GO:000931419 | Esophagus | ESCC | response to radiation | 277/8552 | 456/18723 | 4.42e-11 | 1.43e-09 | 277 |
GO:000941611 | Esophagus | ESCC | response to light stimulus | 183/8552 | 320/18723 | 2.03e-05 | 1.76e-04 | 183 |
GO:003292215 | Esophagus | ESCC | circadian regulation of gene expression | 48/8552 | 68/18723 | 2.76e-05 | 2.30e-04 | 48 |
GO:004851118 | Esophagus | ESCC | rhythmic process | 164/8552 | 298/18723 | 6.80e-04 | 3.57e-03 | 164 |
GO:000762319 | Esophagus | ESCC | circadian rhythm | 119/8552 | 210/18723 | 8.47e-04 | 4.36e-03 | 119 |
GO:00427529 | Esophagus | ESCC | regulation of circadian rhythm | 68/8552 | 121/18723 | 1.27e-02 | 4.21e-02 | 68 |
GO:000838020 | Oral cavity | OSCC | RNA splicing | 308/7305 | 434/18723 | 2.43e-42 | 7.70e-39 | 308 |
GO:000037519 | Oral cavity | OSCC | RNA splicing, via transesterification reactions | 225/7305 | 324/18723 | 5.20e-29 | 2.99e-26 | 225 |
GO:000037719 | Oral cavity | OSCC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 221/7305 | 320/18723 | 5.50e-28 | 2.18e-25 | 221 |
GO:000039819 | Oral cavity | OSCC | mRNA splicing, via spliceosome | 221/7305 | 320/18723 | 5.50e-28 | 2.18e-25 | 221 |
GO:000641720 | Oral cavity | OSCC | regulation of translation | 274/7305 | 468/18723 | 4.39e-18 | 4.63e-16 | 274 |
GO:000931416 | Oral cavity | OSCC | response to radiation | 241/7305 | 456/18723 | 9.76e-10 | 2.40e-08 | 241 |
GO:004851116 | Oral cavity | OSCC | rhythmic process | 157/7305 | 298/18723 | 1.00e-06 | 1.36e-05 | 157 |
GO:000762316 | Oral cavity | OSCC | circadian rhythm | 110/7305 | 210/18723 | 5.40e-05 | 4.48e-04 | 110 |
GO:00094164 | Oral cavity | OSCC | response to light stimulus | 159/7305 | 320/18723 | 5.98e-05 | 4.92e-04 | 159 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RBM4B | SNV | Missense_Mutation | novel | c.655G>A | p.Asp219Asn | p.D219N | Q9BQ04 | protein_coding | tolerated(0.06) | benign(0) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
RBM4B | SNV | Missense_Mutation | novel | c.608T>G | p.Met203Arg | p.M203R | Q9BQ04 | protein_coding | tolerated(0.61) | benign(0) | TCGA-21-1081-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
RBM4B | SNV | Missense_Mutation | c.219N>C | p.Lys73Asn | p.K73N | Q9BQ04 | protein_coding | deleterious(0) | benign(0.41) | TCGA-33-4566-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
RBM4B | SNV | Missense_Mutation | rs759274499 | c.1039N>T | p.Arg347Trp | p.R347W | Q9BQ04 | protein_coding | deleterious(0) | possibly_damaging(0.72) | TCGA-BR-4256-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
RBM4B | SNV | Missense_Mutation | c.280N>A | p.Leu94Ile | p.L94I | Q9BQ04 | protein_coding | deleterious(0.03) | possibly_damaging(0.836) | TCGA-BR-6452-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RBM4B | SNV | Missense_Mutation | rs201202684 | c.668N>A | p.Arg223Gln | p.R223Q | Q9BQ04 | protein_coding | deleterious(0.02) | possibly_damaging(0.849) | TCGA-BR-8363-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RBM4B | SNV | Missense_Mutation | c.371C>T | p.Ala124Val | p.A124V | Q9BQ04 | protein_coding | deleterious(0) | possibly_damaging(0.641) | TCGA-CG-4437-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
RBM4B | SNV | Missense_Mutation | novel | c.874N>A | p.Ala292Thr | p.A292T | Q9BQ04 | protein_coding | tolerated(0.52) | benign(0.073) | TCGA-CG-5721-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
RBM4B | SNV | Missense_Mutation | novel | c.137N>A | p.Thr46Lys | p.T46K | Q9BQ04 | protein_coding | tolerated(0.5) | benign(0.013) | TCGA-D7-6526-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | SD |
RBM4B | SNV | Missense_Mutation | novel | c.472N>C | p.Asp158His | p.D158H | Q9BQ04 | protein_coding | deleterious(0.01) | benign(0.289) | TCGA-VQ-AA64-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | PD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |